<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Fri, 22 Aug 2025 10:36:36 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>#VisualAbstract: Alteplase Improves Outcomes in Acute Ischemic Stroke</title><link>https://www.2minutemedicine.com/visualabstract-alteplase-improves-outcomes-in-acute-ischemic-stroke/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/08/2MM_08.10.25_Astrid_2_Stroke-300x300.jpg</image_url><description>Click here to read this study in JAMA. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Fri, 22 Aug 2025 15:00:44 GMT</pubDate></item><item><title>#VisualAbstract: Vepdegestrant Increased Progres-sion-Free Survival in Advaced Breast 2m TM Cancer with ESR1 Mutations</title><link>https://www.2minutemedicine.com/visualabstract-vepdegestrant-increased-progres-sion-free-survival-in-advaced-breast-2m-tm-cancer-with-esr1-mutations/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/08/2MM_VA_11Aug2025-300x300.jpg</image_url><description>Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Fri, 22 Aug 2025 15:00:25 GMT</pubDate></item><item><title>Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women</title><link>https://www.2minutemedicine.com/extended-aromatase-inhibitor-therapy-reduces-breast-cancer-recurrence-in-postmenopausal-women/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/01/breast_MRI_edited-300x150.jpg</image_url><description>1. Invasive breast cancer recurrence was significantly reduced with extended aromatase inhibitor therapy. 2. No significant reduction was noted for br...</description><pubDate>Thu, 21 Aug 2025 22:55:11 GMT</pubDate></item><item><title>GSK and Hengrui Pharma Forge $500 Million China Collaboration</title><link>https://www.2minutemedicine.com/gsk-and-hengrui-pharma-forge-500-million-china-collaboration/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/03/hospital-300x150.jpg</image_url><description>Key Points: 1. GSK paid $500 million upfront for global development rights to Hengrui’s portfolio of up to 12 early-stage assets. 2. Includes a PDE3/4...</description><pubDate>Thu, 21 Aug 2025 15:15:23 GMT</pubDate></item><item><title>#VisualAbstract: Ciprofloxacin is Noninferior to Aminoglycoside–Ciprofloxacin for Treatment of Bubonic Plague</title><link>https://www.2minutemedicine.com/visualabstract-ciprofloxacin-is-noninferior-to-aminoglycoside-ciprofloxacin-for-treatment-of-bubonic-plague/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/08/2MM_08.10.25_Astrid_1_Plague-300x300.jpg</image_url><description>Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Thu, 21 Aug 2025 15:00:48 GMT</pubDate></item></channel></rss>